Past research has dedicated special emphasis to the pathways involved in AD onset and progression, including amyloid precursor protein processing, Aβ1–42 peptide and tau protein aggregation, autophagy impairment, synaptic derangement, oxidative stress and neuroinflammation [9]. This evidence concerns the gene MAPT and Alzheimer disease.